Immunogen (IMGN) Posts Q4 Loss of 71c/Share
Get Alerts IMGN Hot Sheet
Price: $31.25 --0%
Revenue Growth %: -100.0%
Financial Fact:
Research and development: 32.91M
Today's EPS Names:
MAXN, CSTR, ACU, More
Revenue Growth %: -100.0%
Financial Fact:
Research and development: 32.91M
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Immunogen (NASDAQ: IMGN) reported Q4 EPS of ($0.71), $0.36 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $12.61 million versus the consensus estimate of $15.42 million.
For earnings history and earnings-related data on Immunogen (IMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- Wipro (WIT) Tops Q1 EPS by 1c
- BCB Bancorp (BCBP) Misses Q1 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!